Company intelligence / Profile preview

ITF Research Pharma

Ownership: Private
Development stage: Other

Overview

ITF Research Pharma has developed and advanced estriol-based therapies targeting estrogen receptors. Estriol is approved in Japan for infertility and has been studied in Phase 2 clinical trials for vulvovaginal atrophy. The company focuses on scientific research and development within women's health indications.

Therapeutic areas: Women's Health
Modalities: Small moleculeHormone (Estriol)
Industry: Biotech

Partnerships

Aspen Pharma Trading Ltd.Mochida Pharmaceutical Co., Ltd.

Beyond the preview

Go deeper on ITF Research Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITF Research Pharma.

Explore the full profile